Nitrofural


Full Generic Medicine Info
Dosage/Direction for Use

Topical/Cutaneous
Wounds, burns, ulcers and skin infections, Preparation of surfaces before skin grafting
Adult: Apply as 0.2% topical preparation in a water-soluble or water-miscible basis to the affected area.
Contraindications
Hypersensitivity. Cross-sensitation may occur with other nitrofuran derivatives.
Special Precautions
G6PD deficiency (oral). Renal impairment.
Adverse Reactions
Oral: Severe peripheral neuropathy. Topical: Sensitisation, generalised allergic skin reactions.
Action
Nitrofural is a nitrofuran derivative bactericidal against a wide spectrum of gram-negative and gram-positive bacteria. It also has activity against trypanosomes.
Storage
Topical/Cutaneous: Store below 25°C.
CIMS Class
Topical Antibiotics
ATC Classification
S02AA02 - nitrofural ; Belongs to the class of antiinfectives used in the treatment of ear infections.
S01AX04 - nitrofural ; Belongs to the class of other antiinfectives. Used in the treatment of eye infections.
D08AF01 - nitrofural ; Belongs to the class of nitrofuran derivative antiseptics. Used in the treatment of dermatological diseases.
P01CC02 - nitrofural ; Belongs to the class of nitrofuran derivative agents. Used in the treatment of leishmaniasis and trypanosomiasis.
B05CA03 - nitrofural ; Belongs to the class of antiinfectives used as irrigating solutions.
D09AA03 - nitrofural ; Belongs to the class of ointment dressings with antiinfectives.
Disclaimer: This information is independently developed by CIMS based on nitrofural from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2023 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in